Neurotrack gives primary care systems a clinically validated platform that connects screening, diagnosis, and care planning in a single workflow. But several other tools are competing for your attention. This guide compares six platforms across the criteria that matter most to decision-makers evaluating scalability, EHR integration, and Medicare Advantage documentation readiness.
If you manage cognitive care for a large patient population, you already know that not every screening tool fits every workflow. We evaluated these platforms with the operational realities of primary care networks top of mind.
Neurotrack is a cognitive care enablement platform built for the specific operational demands of large health systems and value-based primary care groups. Where most tools stop at screening, Neurotrack connects assessment, diagnosis support, and care planning through a single, EHR-integrated workflow powered by its Smart Logic adaptive technology.
The initial assessment takes just three minutes and is self-administered by the patient in clinic or remotely. That saves an average of ten minutes per encounter compared to paper-based tools. Smart Logic dynamically adjusts the assessment in real time based on how each patient responds, then surfaces a structured clinical pathway that gives providers the confidence to move toward diagnosis.
Neurotrack's assessments are clinically validated to detect cognitive impairment at the MCI stage with 94% sensitivity and 90% specificity, exceeding Alzheimer's Association guidelines for Brief Cognitive Assessments. The platform is an FDA Class II registered medical device and is validated across diverse patient populations.
For Medicare Advantage plans and value-based care organizations, Neurotrack produces EHR-ready documentation aligned with CMS V28 guidelines. One partner, Desert Oasis Healthcare, reported a 35% net increase in new dementia diagnoses after implementing the platform. Sutter Health, serving 3.5 million patients, selected Neurotrack as a core component of its dementia detection strategy.
Pros:
Cons:
BrainCheck offers a digital cognitive assessment and care planning platform that spans screening, assessment, and longitudinal follow-up. The platform is used across more than 500 healthcare organizations, including primary care, geriatrics, neurology, and behavioral health settings. BrainCheck Assess evaluates five cognitive domains with automated scoring and is classified as an FDA Class II medical device.
The platform also includes population analytics that use existing EHR data to help clinicians identify and prioritize patients for cognitive review. BrainCheck has published 39 peer-reviewed publications supporting its clinical evidence base and clinical adoption.
Pros:
Cons:
Linus Health offers the Core Cognitive Evaluation (CCE), which pairs Digital Clock and Recall (DCR) with a Life and Health Questionnaire. The underlying AI engine, DCTClock, analyzes how a patient draws a clock to surface subtle impairment patterns that traditional scoring may miss. The platform generates clinical decision support and personalized patient action plans alongside every assessment.
For payer and health-system clients, Linus Health includes a predictive engine called Radar that analyzes claims and clinical data to flag at-risk members before they are screened. The DCR assessment takes approximately two to three minutes.
Pros:
Cons:
Cognivue delivers computerized cognitive assessment through a dedicated proprietary device. Cognivue Thrive takes approximately five minutes, and Cognivue Clarity takes approximately ten minutes. Both assessments are self-administered and automatically scored. Cognivue evaluates multiple cognitive areas including memory, executive function, attention, discrimination, and visuospatial performance.
The platform holds FDA clearance as an adjunctive cognitive assessment aid. Cognivue currently has approximately 4,000 devices deployed in U.S. clinics, with around 100,000 patients completing assessments annually, according to Being Patient reporting on digital cognitive tests.
Pros:
Cons:
Creyos, formerly Cambridge Brain Sciences, offers digital cognitive assessments covering memory, reasoning, concentration, and verbal ability. The underlying cognitive tasks have a substantial academic research history and can be administered in clinic or remotely. A brief screener takes approximately five minutes, while the full battery takes approximately 30 minutes.
Creyos recently partnered with Redox to integrate cognitive testing data into EHR systems at scale. The platform is applicable across primary care, neurology, and behavioral health use cases. Care planning tools are a newer addition to the platform.
Pros:
Cons:
GIA by Scienza Health is a clinical AI screening system that analyzes speech biomarkers from a 40-second natural conversation. The screening runs before the clinical encounter via phone, video, or landline, with results delivered to the physician's EHR in under two minutes. GIA screens for 46 conditions including cognitive decline, depression, anxiety, and PTSD.
The platform is validated across 19 peer-reviewed speech biomarker studies and integrates with Epic, Cerner, MatrixCare, PointClickCare, and other HL7 FHIR-compliant systems. GIA requires no clinician or staff time during the screening interaction.
Pros:
Cons:
| Platform | Care Planning | Patient Self-Administered | Assessment Time |
|---|---|---|---|
| Neurotrack | ✓ | ✓ | 3 min |
| BrainCheck | ✓ | ✓ | 3–15 min |
| Linus Health | ✓ | ✓ | 2–8 min |
| Cognivue | ✓ | 5–10 min | |
| Creyos | ✓ | ✓ | 5–30 min |
| Scienza Health (GIA) | ✓ | 40 sec |
Before committing to any platform, health system leaders should map the tool's capabilities against three operational realities: clinical workflow integration, IT deployment complexity, and documentation requirements.
Start with workflow fit. If a tool adds more than a few minutes to a standard encounter or requires dedicated staff to administer, adoption will stall at the clinic level regardless of clinical performance. Self-administered, patient-led assessments reduce that friction significantly.
Then evaluate EHR integration depth. A tool that writes structured results, diagnostic pathways, and care plans directly into your existing EHR eliminates the manual documentation burden that causes most screening programs to lose momentum after initial rollout. Neurotrack integrates directly into existing EHR environments, producing documentation aligned with CMS V28 requirements.
Medicare Advantage plans require documentation that supports accurate risk adjustment under the CMS V28 model. This means cognitive screening results must clearly map to specific severity tiers for HCC coding: mild, moderate, and severe. The documentation needs to meet MEAT criteria (Monitoring, Evaluation, Assessment, Treatment) to be audit-defensible.
Many traditional screening tools produce a single numeric score that requires clinicians to manually translate results into compliant documentation. Digital platforms that generate structured, EHR-ready reports aligned with V28 categories reduce that translation burden and support more accurate risk capture.
According to a 2025 study in Annals of Family Medicine, integrating digital cognitive assessments into primary care workflows through structured implementation processes improved both screening rates and documentation quality across multiple clinic sites.
When you are managing cognitive care across a large primary care network, the screening tool itself is only one part of the equation. What happens after a positive result, how quickly providers can move from detection to diagnosis to a care plan, determines whether your screening program actually improves patient outcomes or just generates data.
Neurotrack connects every stage of that process. The platform's Smart Logic technology adapts each assessment in real time, then surfaces a structured clinical pathway that gives your providers the confidence to act on what they are seeing. That is why organizations like Sutter Health and Desert Oasis Healthcare have chosen Neurotrack as the foundation of their cognitive care strategies.
For Medicare Advantage plans and value-based care groups, Neurotrack delivers the documentation readiness that supports accurate V28 risk adjustment and quality performance. With clinically validated assessments, direct EHR integration, and care planning support in a single platform, Neurotrack gives health system leaders the tools to close the cognitive care gap at scale. See Neurotrack in action.
A digital cognitive screening tool is software that evaluates cognitive function through standardized, electronically administered tasks. Neurotrack uses clinically validated digital assessments that patients complete in approximately three minutes, with results scored automatically and delivered directly into the provider's EHR.
Administration time varies by platform. Neurotrack's Core Cognitive Panel takes approximately three minutes and saves an average of ten minutes per encounter compared to traditional paper-based tools. Some platforms require five to 30 minutes depending on the assessment depth selected.
Many digital platforms offer EHR integration, but the depth of that integration varies significantly. Neurotrack writes assessment results, structured clinical pathways, and care plans directly into your EHR, eliminating the need for manual data entry. Other tools may require middleware or manual documentation steps.
CMS requires detection of cognitive impairment as part of the Medicare Annual Wellness Visit. Under the V28 model, dementia is coded across three severity tiers. Neurotrack generates structured documentation aligned with these requirements, supporting accurate risk adjustment and audit-defensible records.
Traditional tools like MoCA and MMSE take 10 to 15 minutes of clinician-administered time and require manual scoring. Neurotrack's three-minute, patient-led digital assessment is clinically validated with 94% sensitivity and 90% specificity, which exceeds the performance of many conventional screening instruments.